SymphytineCAS# 22571-95-5 |
2D Structure
- Echiumine
Catalog No.:BCN1972
CAS No.:633-16-9
- Symlandine
Catalog No.:BCN1974
CAS No.:74410-74-5
- Myoscorpine
Catalog No.:BCN1973
CAS No.:82535-76-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 22571-95-5 | SDF | Download SDF |
PubChem ID | 6435910 | Appearance | Powder |
Formula | C20H31NO6 | M.Wt | 381.47 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [(7S,8R)-7-[(E)-2-methylbut-2-enoyl]oxy-5,6,7,8-tetrahydro-3H-pyrrolizin-1-yl]methyl 2-hydroxy-2-(1-hydroxyethyl)-3-methylbutanoate | ||
SMILES | CC=C(C)C(=O)OC1CCN2C1C(=CC2)COC(=O)C(C(C)C)(C(C)O)O | ||
Standard InChIKey | MVWPTZQHBOWRTF-VJNCLFHASA-N | ||
Standard InChI | InChI=1S/C20H31NO6/c1-6-13(4)18(23)27-16-8-10-21-9-7-15(17(16)21)11-26-19(24)20(25,12(2)3)14(5)22/h6-7,12,14,16-17,22,25H,8-11H2,1-5H3/b13-6+/t14?,16-,17+,20?/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Symphytine and senkirkine, the pyrrolizidine alkaloids, have carcinogenicity. |
Symphytine Dilution Calculator
Symphytine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6214 mL | 13.1072 mL | 26.2144 mL | 52.4288 mL | 65.536 mL |
5 mM | 0.5243 mL | 2.6214 mL | 5.2429 mL | 10.4858 mL | 13.1072 mL |
10 mM | 0.2621 mL | 1.3107 mL | 2.6214 mL | 5.2429 mL | 6.5536 mL |
50 mM | 0.0524 mL | 0.2621 mL | 0.5243 mL | 1.0486 mL | 1.3107 mL |
100 mM | 0.0262 mL | 0.1311 mL | 0.2621 mL | 0.5243 mL | 0.6554 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Zeorin
Catalog No.:BCN5067
CAS No.:22570-53-2
- Bisabolol Oxide A
Catalog No.:BCC8133
CAS No.:22567-36-8
- Isocryptotanshinone
Catalog No.:BCN2499
CAS No.:22550-15-8
- Robustine
Catalog No.:BCN6653
CAS No.:2255-50-7
- Ocotillone
Catalog No.:BCN5066
CAS No.:22549-21-9
- CTU Guanamine
Catalog No.:BCC8921
CAS No.:22535-90-6
- 8-Hydroxy-9,10-diisobutyryloxythymol
Catalog No.:BCN7786
CAS No.:22518-08-7
- Cathepsin Inhibitor 1
Catalog No.:BCC4896
CAS No.:225120-65-0
- Falcarindiol
Catalog No.:BCN5065
CAS No.:225110-25-8
- IDRA 21
Catalog No.:BCC6974
CAS No.:22503-72-6
- N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide
Catalog No.:BCN1483
CAS No.:2249289-10-9
- Erigeside I
Catalog No.:BCN7172
CAS No.:224824-74-2
- PAR 4 (1-6)
Catalog No.:BCC3956
CAS No.:225779-44-2
- Epifriedelanol acetate
Catalog No.:BCN5068
CAS No.:2259-07-6
- Cyclothiazide
Catalog No.:BCC6759
CAS No.:2259-96-3
- (+)-Catechin hydrate
Catalog No.:BCN2309
CAS No.:225937-10-0
- Lucidioline
Catalog No.:BCN7413
CAS No.:22594-91-8
- Auriculine
Catalog No.:BCN2013
CAS No.:22595-00-2
- Demethoxycurcumin
Catalog No.:BCN5974
CAS No.:22608-11-3
- Kulactone
Catalog No.:BCN7953
CAS No.:22611-36-5
- Methyl kulonate
Catalog No.:BCN7952
CAS No.:22611-37-6
- Cinacalcet
Catalog No.:BCC1483
CAS No.:226256-56-0
- Torachrysone
Catalog No.:BCN5069
CAS No.:22649-04-3
- 4,6,7-Trihydroxycoumarin
Catalog No.:BCC9203
CAS No.:22649-24-7
Induction of hepatic tumors in rats by senkirkine and symphytine.[Pubmed:287835]
J Natl Cancer Inst. 1979 Aug;63(2):469-72.
The carcinogenicity of the pyrrolizidine alkaloids senkirkine and Symphytine was studied in male inbred ACI rats. Animals were divided into 3 groups: Group I received ip injections of freshly prepared senkirkine at a dose of 10% of the median lethal dose (LD50) twice weekly for 4 weeks and then once a week for 52 weeks. Group II received ip injections of Symphytine at a dose of 10% of the LD50 by the same injection schedule as in group I. The control group was given ip injections of a 0.9% NaCl solution following the same injection schedule as in experimental groups. All group I rats survived for more than 290 days after the start of injections, and 9 of 20 rats developed liver cell adenoma. All group II animals survived for more than 330 days after the start of injections. Of 20 rats, 4 had liver tumors, 3 had hemangioendothelial sarcomas, and 1 had liver cell adenoma. The hemangioendothelial sarcomas showed metastasis in the lungs of 2 rats. The control group had no liver tumors.
Analysis of herbal teas made from the leaves of comfrey (Symphytum officinale): reduction of N-oxides results in order of magnitude increases in the measurable concentration of pyrrolizidine alkaloids.[Pubmed:15482618]
Public Health Nutr. 2004 Oct;7(7):919-24.
OBJECTIVES: To determine the relative quantities of two hepatotoxic pyrrolizidine alkaloids, Symphytine and echimidine, in teas prepared from comfrey leaves (Symphytum officinale), and to determine the potential contribution of the N-oxide forms of these alkaloids to levels of the parent alkaloids. DESIGN: Comfrey leaves were purchased from three commercial sources and used to prepare tea in a manner consistent with the methods used by consumers. An extraction scheme was devised for extraction of the alkaloids, and a gas chromatographic method was developed to quantify the two major alkaloids, Symphytine and echimidine. Recognising that the N-oxide derivatives of these alkaloids have also been identified in comfrey preparations, chemical reduction was applied to determine the total quantities of the alkaloids as free bases and as N-oxide derivatives. RESULTS: The concentration of Symphytine and echimidine varied considerably between teas prepared from leaves purchased from the different vendors of plant material. Moreover, a much higher concentration of Symphytine was found in the tea when steps were included to reduce N-oxides prior to analysis. The treatment of pure Symphytine with hot water did not generate the N-oxide derivative de novo. CONCLUSIONS: Since the pyrrolizidine alkaloids are known to be hepatotoxic, consumption of herbal teas made from comfrey leaves may be ill-advised. The concentration of pyrrolizidine alkaloids in such teas may be underestimated substantially unless the concentration of N-oxides is taken into consideration.